Heat biologics, inc. (HTBX)
CashFlow / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12
Cash Flows from Operating Activities
Net loss

-20,384

-16,591

-12,409

-12,974

-21,121

-12,243

-6,609

-

Net Loss

-

-

-

-

-

-

-

-2,471

Adjustments to reconcile net loss to net cash used in operating activities:
Goodwill impairment loss

737

-

-

-

-

-

-

-

Depreciation and amortization

232

237

-

-

-

-

-

-

Noncash lease expense

39

-

-

-

-

-

-

-

Noncash interest expense

0

-

-

-

-

-

-

-

Non-cash consideration for rent

-

-

-

-

-

-

-

0

Stock-based compensation

3,269

788

689

582

1,573

1,066

571

217

Loss on disposal of equipment

-11

-

-

-

-

-

-

-

Depreciation

-

-

134

132

115

67

6

2

Amortization of deferred financing costs and debt issuance costs

-

-

-

218

101

38

28

58

Amortization of held to maturity investment premium

-

-

-

32

142

173

-

-

Amortization of bond premium

-

-

-

-

-

-

50

0

Change in fair value of common stock warrants

-

-

-

-

-

7

30

3

Change in fair value of contingent consideration

613

495

224

0

-

-

-

-

Unrealized gain on investments

5

-0

-

-

-

-

-

-

Increase (decrease) in cash arising from changes in assets and liabilities:
Accounts receivable

6

14

-67

82

0

-

-

-

Prepaid expenses and other current assets

-540

-1,000

1,624

-532

32

-203

1,008

52

Deposits

-

-

-

-

50

10

-

-

Related party receivable

-

-

-

45

9

24

15

9

Restricted cash

-

-

-

-

-

100

-24

24

Deferred financing costs

-

-30

30

0

-

-

-

-

Operating lease right-of-use asset

590

-

-

-

-

-

-

-

Accounts payable

529

-55

-175

-1,690

642

716

146

85

Deferred revenue

2,377

-5,793

7,026

0

-

-

-

-

Deferred tax liability

45

-985

-809

0

-

-

-

-

Accrued expenses and other liabilities

8

-595

806

-542

1,040

303

373

103

Other long-term liabilities

-213

53

-300

311

149

0

-

-

Deposits

43

281

-

-

-

-

-

-

Deposits

-

-

-

-

-

-

0

0

Accrued interest

-

-

-

-

-

-25

11

13

Net Cash Used in Operating Activities

-

-

-

-

-17,447

-9,829

-

-

Net Cash Used in Operating Activities

-12,837

-21,711

-6,402

-13,523

-

-

-6,388

-2,073

Cash Flows from Investing Activities
Proceeds from maturities of short-term investments

-

-

-

6,656

14,956

18,624

0

-

Purchase of Pelican, net

-

-

468

0

-

-

-

-

Purchase of short-term investments

138

5,570

-

-

11,090

12,199

17,347

0

Purchase of property and equipment

265

593

61

45

115

459

49

1

Proceeds from disposal of property and equipment

109

-

-

-

-

-

-

-

Net Cash (Used in) Provided by Investing Activities

-

-

-

-

3,751

5,966

-

-

Net Cash Used in Investing Activities

-293

-6,163

-530

6,610

-

-

-17,397

-1

Cash Flows from Financing Activities
Proceeds from public offering of common stock and warrants, net of issuance costs

-

34,499

6,629

6,287

11,400

-

25,110

0

Borrowings on line of credit

-

-

-

-

-

-

-

0

Payments on notes payable

-

-

-

-

-

-

925

225

Payments on line of credit

-

-

-

-

-

-

-

0

Issuance of convertible notes payable, net of issuance costs

-

-

-

-

-

-

-197

197

Proceeds from the issuance of common stock, net of underwriting discounts and commissions

18

3,910

2,463

7,082

0

-

0

11

Proceeds from long term debt, net

-

-

-

-

-

-

0

-

Related party payable

-

-

-

-

-

-

-

12

Proceeds from issuance of long term debt, net

-

-

-

-

4,470

2,973

200

950

Payments on long term debt

-

-

-

6,941

558

0

-

-

Proceeds from exercise of stock options

2

-

-

-

-

37

54

0

Proceeds from exercise of warrants

-

4,838

-

3,863

0

-

-

-

Stock issuance costs

-

3,130

324

488

302

0

944

22

Repayments on principal of finance lease

1

-

-

-

-

-

-

-

Net Cash Provided by Financing Activities

-

-

-

-

15,011

3,010

-

-

Net Cash Provided by Financing Activities

19

40,118

8,768

9,802

-

-

28,348

1,981

Effect of exchange rate changes on cash and cash equivalents

-1

145

-14

12

-89

0

-

-

Net Change in Cash and Cash Equivalents

-13,114

12,388

1,821

-

-

-

-

-

Payments on convertible notes payable

-

-

-

-

-

-

-

0

Net Increase in Cash and Cash Equivalents

-

-

-

2,902

1,225

-853

4,561

-93

Supplemental Disclosure for Cash Flow Information:
Operating lease right-of-use assets obtained with lease liabilities

1,945

-

-

-

-

-

-

-

Finance lease right-of-use assets obtained with lease liabilities

192

-

-

-

-

-

-

-

Acquisition of non-controlling interest of Heat I/Pelican

-

2,400

-

-

-

-

-

-

Contingent consideration

-

-

2,385

0

-

-

-

-

Issuance of common stock for purchase of Pelican

-

-

1,052

0

-

-

-

-

Interest paid

-

-

-

330

-

-

-

-

Acquisition of non-controlling interest of Heat I/Pelican

-

2,400

-

-

-

-

-

-

Interest paid

-

-

-

-

262

32

60

29

Supplemental disclosure of non-cash investing and financing activities:
Cashless exercise of stock options

-

-

-

-

32

0

-

-

Beneficial conversion charge

-

-

-

-

-

-

-2,300

0

Cancellation of common stock

-

-

-

-

-

-

-

0

Non-cash consideration for rent

-

-

-

-

-

-

-

0

Non-cash conversion of preferred stock into common stock

-

-

-

-

-

-

0

0

Preferred conversion of preferred stock into common stock

-

-

-

-

-

-

361

0

Cashless exercise of stock warrants

-

-

-

-

-

453

0

-

Issuance of warrants

-

-

-

-

-

323

-

31

Issuance of warrants

-

-

-

-

-

-

0

-